These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 6351756)

  • 1. Mechanisms of immunologic injury. Pemphigus and bullous pemphigoid.
    Anhalt GJ; Patel H; Diaz LA
    Arch Dermatol; 1983 Sep; 119(9):711-4. PubMed ID: 6351756
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunologic phenomena in the skin of patients with pemphigoid in relation to the pathologic process].
    Torzecka JD; Lutowiecka-Wranicz A; Sysa-Jedrzejowska A; Waszczykowska E; Dziankowska-Bartkowiak B
    Przegl Dermatol; 1988; 75(4):266-71. PubMed ID: 3070636
    [No Abstract]   [Full Text] [Related]  

  • 3. Bullous pemphigoid and pemphigus vulgaris.
    Patel HP; Anhalt GJ; Diaz LA
    Ann Allergy; 1983 Mar; 50(3):144-50. PubMed ID: 6338766
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.
    Brooks WS; Lee YY; Abell E; Deng JS
    J Clin Lab Anal; 1989; 3(5):307-11. PubMed ID: 2681622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.
    Stanley JR
    J Clin Invest; 1989 May; 83(5):1443-8. PubMed ID: 2651476
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunopathology of pemphigus vulgaris, bullous pemphigoid and related bullous dermatoses.
    Patel HP; Anhalt GJ; Provost TT; Diaz LA
    Clin Immunol Rev; 1983-1984; 2(2):157-86. PubMed ID: 6370527
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunopathologic mechanisms in pemphigus and bullous pemphigoid.
    Jordon RE; Kawana S; Fritz KA
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):72s-78s. PubMed ID: 3891883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis of bullous pemphigoid in the light of modern immunologic knowledge].
    Remy W
    Fortschr Med; 1977 Nov; 95(42):2553-8. PubMed ID: 334658
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential role of interleukin-17 in the pathogenesis of bullous pemphigoid.
    Toosi S; Bystryn JC
    Med Hypotheses; 2010 Apr; 74(4):727-8. PubMed ID: 19945799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [On the autoimmune pathogenesis of bullous pemphigoid. Review of the literature and our results (author's transl)].
    Haustein UF; Lohrisch I; Herrmann K
    Dermatol Monatsschr; 1980 Sep; 166(9):585-98. PubMed ID: 7004925
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunohistochemical study on 70 human embryos concerning the epidermal binding of pemphigus and pemphigoid antibodies.
    Varelzidis A; Tosca A; Coumantakis E; Nicolis G; Hatzis J; Papavasiliou S; Stratigos J
    Acta Derm Venereol; 1980; 60(2):129-33. PubMed ID: 6155018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A functional assay for complement-activating antibodies to the cutaneous basement membrane zone.
    Gammon WR; Merritt CC
    Ann N Y Acad Sci; 1983; 420():335-42. PubMed ID: 6372599
    [No Abstract]   [Full Text] [Related]  

  • 13. A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens.
    Darling TN; Cardenas AA; Beard JS; Sau P; Yee CL; Zone JJ; Yancey KB
    Arch Dermatol; 1995 Dec; 131(12):1438-42. PubMed ID: 7492135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopathological techniques in the diagnosis of bullous disorders.
    Black MM; Bhogal BS; Willsteed E
    Acta Derm Venereol Suppl (Stockh); 1989; 151():96-105; discussion 106-10. PubMed ID: 2696314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro organ culture model for mucous membrane pemphigoid.
    Colón JE; Bhol KC; Razzaque MS; Ahmed AR
    Clin Immunol; 2001 Feb; 98(2):229-34. PubMed ID: 11161979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of the biotin-avidin system to the study of autoimmune bullous diseases: immunofluorescence method using biotinylated-pemphigus and -pemphigoid antibodies and fluoresceinated avidin].
    Muramatsu T; Sakamoto K; Ikeda S
    Nihon Hifuka Gakkai Zasshi; 1988 Sep; 98(10):977-80. PubMed ID: 3065537
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of autoantibodies in autoimmune bullous skin diseases: can we do better?
    Baum S; Zafrir Y; Barzilai A
    Isr Med Assoc J; 2014 Apr; 16(4):244-5. PubMed ID: 24834762
    [No Abstract]   [Full Text] [Related]  

  • 18. IgG4, complement, and the mechanisms of blister formation in pemphigus and bullous pemphigoid.
    Dainichi T; Chow Z; Kabashima K
    J Dermatol Sci; 2017 Dec; 88(3):265-270. PubMed ID: 28747266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular biological aspects of acquired bullous diseases.
    Dabelsteen E
    Crit Rev Oral Biol Med; 1998; 9(2):162-78. PubMed ID: 9603234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distribution of IgG subclasses in pemphigoid gestationis: PG factor is an IgG1 autoantibody.
    Kelly SE; Cerio R; Bhogal BS; Black MM
    J Invest Dermatol; 1989 May; 92(5):695-8. PubMed ID: 2654296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.